FDA calls for investigation into its approval of controversial Alzheimer’s drug
By
Alicia Lasek
Jul 12, 2021
The acting chief of the Food and Drug Administration has called for an investigation into the events leading up to the approval of Biogen’s brain plaque-clearing dementia drug aducanumab (Aduhelm).
A first: FDA approves drug to treat agitation in Alzheimer’s dementia
By
Alicia Lasek
May 12, 2023
For the first time, the FDA has approved a drug to treat agitation related to Alzheimer’s disease dementia. Patient advocates are hailing the news, but prescribing the drug, an antipsychotic, may put...
Teen astounds with solution for wandering monitoring today, Alzheimer’s next?
By
James M. Berklan
Nov 11, 2015
Kenneth Shinozuka modestly aspires to find a cure for Alzheimer’s disease, and he might be just the guy to do it. He’s already created a personal sensoring system that could revolutionize the...
Rockin’ the (nursing home) casbah
By
Mary Gustafson
Feb 16, 2012
While idly watching the Grammy Awards broadcast on Sunday night, I tried to keep a mostly apathetic eye on various social media networks. It was here that I learned — among other pretty useless information...
In dementia’s crosshairs, women speak out
By
Tim Mullaney
Mar 25, 2014
Alzheimer’s disease does not discriminate. Or so we’ve been repeatedly told — for example, when “Iron Lady” Margaret Thatcher died, almost exactly one year ago. But a report out...